The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 138 participants.

Also called NCT02370069

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 138 participants (enrolled count) (from the registry)
Sponsor
Lakehead University (from the registry)
Registry
  • NCT NCT02370069
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02370069. Non-randomized; single masking; primary purpose prevention. Start 2015-06 (actual); primary completion 2020-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13
Condition
Chronic Kidney Diseases
Intervention (Biological)
Prevnar 13
Lead sponsor
Lakehead University (class: other)

Record details

Record id
cardio:ct-nct02370069
Content hash
7228381fcc22910453b888efa71787417634f9d8a63c345ef010b746365ddedd